Cargando…

Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy

RATIONALE: Regorafenib represents a treatment option in heavily pretreated patients affected by metastatic colorectal cancer (mCRC). Its safety profile is typical of small-molecule tyrosine-kinase inhibitors (TKIs) and most adverse events are manageable. PATIENT CONCERNS: A 56 years-old Caucasian ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quirino, Michela, Rossi, Sabrina, Schinzari, Giovanni, Basso, Michele, Strippoli, Antonia, Cassano, Alessandra, Barone, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406055/ https://www.ncbi.nlm.nih.gov/pubmed/28422839 http://dx.doi.org/10.1097/MD.0000000000006522

Ejemplares similares

Gastrointestinal stromal tumors (GISTs) and second malignancies: A novel “sentinel tumor”? A monoinstitutional, STROBE-compliant observational analysis
por: Rodriquenz, Maria Grazia, et al.
Publicado: (2016)

Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab
por: Basso, Michele, et al.
Publicado: (2016)

Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature
por: Mitani, Seiichiro, et al.
Publicado: (2017)

mCRC: rasante Weiterentwicklung zielgerichteter Therapien
por: Arnheim, Katharina
Publicado: (2022)

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)
por: Rossi, Luigi, et al.
Publicado: (2013)

A phase II trial of the effect of perindopril on hand–foot skin reaction (HFSR) incidence and severity in patients receiving regorafenib for refractory mCRC
por: Melosky, Barbara L., et al.
Publicado: (2018)

Non-Hyperammonemic valproate encephalopathy
por: Farooq, Omar, et al.
Publicado: (2014)

Valproate-Induced Hyperammonemic Encephalopathy
por: Farooq, Faiza, et al.
Publicado: (2017)

Nivolumab plus regorafenib in patients with small bowel adenocarcinoma: A case report
por: Zhang, Gairong, et al.
Publicado: (2021)

The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients
por: Yu, Ping, et al.
Publicado: (2018)

Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial
por: Marmorino, Federica, et al.
Publicado: (2019)

The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
por: Yuan, Meiqin, et al.
Publicado: (2022)

Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment
por: Chen, Hong-Hwa, et al.
Publicado: (2021)

The role of stereotactic body radiation therapy in oligometastatic colorectal cancer: Clinical case report of a long-responder patient treated with regorafenib beyond progression
por: Roberto, Michela, et al.
Publicado: (2017)

Multiple Myeloma-Induced Hyperammonemic Encephalopathy
por: Murtaza, Ghulam, et al.
Publicado: (2017)

Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies
por: Rossi, Sabrina, et al.
Publicado: (2017)

Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?
por: Saif, Muhammad Wasif
Publicado: (2013)

Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study
por: Marrari, Andrea, et al.
Publicado: (2020)

Regorafenib-induced retinal and gastrointestinal hemorrhage in a metastatic colorectal cancer patient with liver dysfunction: A case report
por: Tsuchihashi, Kenji, et al.
Publicado: (2017)

A Case of Valproate Induced Hyperammonemic Encephalopathy
por: Tarafdar, Surjit, et al.
Publicado: (2011)

Valproate induced hyperammonemic encephalopathy treated by haemodialysis
por: Chauhan, Vinay Singh, et al.
Publicado: (2017)

Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
por: Suarez, Oscar, et al.
Publicado: (2018)

Delayed Cerebral Abnormalities in Acute Hyperammonemic Encephalopathy
por: Ito, Hiroshi, et al.
Publicado: (2020)

A Case of Valproate-Induced Hyperammonemic Encephalopathy
por: Zafar, Faraaz, et al.
Publicado: (2020)

Reversible hyperammonemic encephalopathy after gastrointestinal bleeding
por: Boku, Keishun, et al.
Publicado: (2021)

Hyperammonemic Encephalopathy Secondary to Urinary Tract Infection
por: Gorantla, Asher, et al.
Publicado: (2022)

Quality and practical aspects of pathological and molecular diagnostics in metastatic colorectal cancer (mCRC)
por: Tysarowski, Andrzej, et al.
Publicado: (2018)

Maximising clinical benefit with adequate patient management beyond the second line in mCRC
por: Argiles, Guillem, et al.
Publicado: (2019)

Therapeutic effects of regorafenib after sorafenib monotherapy with advanced hepatocellular carcinoma including Child–Pugh classification B: A retrospective observational study
por: Komiyama, Satoshi, et al.
Publicado: (2020)

MRI Findings in Acute Hyperammonemic Encephalopathy: Three Cases of Different Etiologies: Teaching Point: To recognize MRI findings in acute hyperammonemic encephalopathy
por: Reis, Elisabeth, et al.
Publicado: (2020)

Comparative efficacy and safety for second-line treatment with ramucirumab, regorafenib, and cabozantinib in patients with advanced hepatocellular carcinoma progressed on sorafenib treatment: A network meta-analysis
por: Chen, Jianxin, et al.
Publicado: (2021)

Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction
por: Twilla, Jennifer D., et al.
Publicado: (2014)

Magnetic resonance imaging of brain findings in hyperammonemic encephalopathy
por: Pulivarthi, Swaroopa, et al.
Publicado: (2016)

Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014)

Hyperammonemic Encephalopathy: A Complication of Gastric Bypass Surgery
por: Reddy, Varun, et al.
Publicado: (2020)

Valproate-induced hyperammonemic encephalopathy: a case report
por: Shah, Suhal, et al.
Publicado: (2020)

Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma
por: Thakral, Nimish, et al.
Publicado: (2020)

A Mysterious Case of Recurrent Acute Hyperammonemic Encephalopathy
por: Pendela, Venkata Satish, et al.
Publicado: (2020)

Hyperammonemic Encephalopathy: A Unique Presentation of Multiple Myeloma
por: Douedi, Steven, et al.
Publicado: (2021)

A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy
por: Iqbal, Kinza, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jcp3jkbm7dpb94v303tc69ul7a